Purple Innovation, Inc. current report, 13 February 2023

Full document

Business Context and Reporting Period

This Form 8-K was filed by Purple Innovation, Inc. on February 13, 2023. The report addresses a significant corporate governance event involving a shareholder nomination contest for the 2023 Annual Meeting of Stockholders.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial performance data.

Material Changes

On February 13, 2023, Coliseum Capital Partners, L.P. (Coliseum) submitted a notice of nomination for a slate of five director candidates for election at the Company's 2023 Annual Meeting. Coliseum simultaneously filed a Schedule 13D/A, a DEF 14A, and a press release disclosing this action.

Guidance, Outlook, and Risks

  • Management Commentary: The Company intends to file a definitive proxy statement on Schedule 14A and a WHITE proxy card to solicit proxies for the 2023 Annual Meeting.
  • Shareholder Action: Shareholders are strongly encouraged to read the definitive proxy statement and all related SEC filings carefully when available.
  • Risks and Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements, noting that actual results may differ due to risks outlined in the Company's 2022 Form 10-K. Specific risks mentioned include the exacerbation of uncertainties by the COVID-19 pandemic and the global economic environment.

Important Facts for Investors to Verify

  • Review the definitive proxy statement (Schedule 14A) once filed to compare the Company's board nominees against Coliseum Capital Partners' slate.
  • Examine the Schedule 13D/A filed by Coliseum to understand their ownership stake and stated reasons for the nomination.
  • Monitor the Company's Investor Relations website and SEC filings for updates on the proxy solicitation process.
  • Verify the Company's current financial health and risk factors in the most recent Form 10-K, as this 8-K does not contain updated financial metrics.